LI Yi-fan, Li Juan, LU Wen-ping. Effect of Yiqi Huoxue Jiedu Decoction on Proliferation of Ovarian Cancer ID-8 Cells and Angiogenesis[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(4): 154-159.
DOI:
LI Yi-fan, Li Juan, LU Wen-ping. Effect of Yiqi Huoxue Jiedu Decoction on Proliferation of Ovarian Cancer ID-8 Cells and Angiogenesis[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(4): 154-159. DOI: 10.13422/j.cnki.syfjx.2018040154.
Effect of Yiqi Huoxue Jiedu Decoction on Proliferation of Ovarian Cancer ID-8 Cells and Angiogenesis
目的:研究益气活血解毒方抑制鼠卵巢上皮癌ID-8细胞株增殖的作用,并观察本方对于脐静脉内皮细胞(HUVECs)形成血管过程的作用,为本方发挥疗效提供实验依据。方法:采用细胞增殖与检测方法(cell counting kit-8,CCK-8)检测本方对于ID-8细胞增殖的抑制作用;将含中药血清、磁珠分选的调节性T细胞(regulatory T cells,Tregs)与抗血管内皮生长因子(VEGF)抗体分组共培养,观察血管生成情况差异。结果:与空白组比较,10%,20%含药血清均能够抑制卵巢上皮癌ID-8细胞株的增殖,此抑制作用在培养96 h时最明显;在72,96 h时,20%含药血清组的抑制率明显高于10%含药血清组(P<0.05,P<0.01)。与Tregs(-)各组相比,Tregs(+)各组HUVECs细胞呈现明显的血管网状结构,中药含药血清组血管成网不明显,VEGF抗体联合含药血清组血管成网情况最差。结论:益气活血解毒方对小鼠卵巢上皮癌ID-8细胞株的增殖过程有显著的抑制作用,同时能够干预血管的形成,这也许与本方影响Tregs促进肿瘤新生血管的作用相关。
Abstract
Objective: To analyze the inhibitory effects of Yiqi Huoxue Jiedu decoction on proliferation of ovarian epithelial carcinoma ID-8 cells in vitro
observe the effect of this method on angiogenesis of human umbilical vein endothelial cells (HUVECs)
and provide experimental basis for its efficacy. Method: Cell counting kit-8 (CCK-8) was used to testify the inhibitory effect of Yiqi Huoxue Jiedu decoction on the proliferation of ovarian cancer ID-8 cells; decoction serum
regulatory T cells (Tregs) isolated by immune magnetic MACS MicroBeads
as well as vascular endothelial growth factors (VEGF) were co-cultured
and then the angiogenesis of HUVEC was observed. Result: As compared with blank control group (fetal bovine serum group)
drug serum groups with concentration of 10% and 20% showed inhibitory effects on ID-8 cells
and this effect was most significant at 96 h. Serum group with concentration of 20% showed remarkable advantages against 10% group at 72 h (P<0.01) and 96 h (P<0.05). HUVECs cultivated with Treg cells exhibited a better angiogenesis process. On the other hand
the vascular network was not obvious in drug serum group
and the inhibitory effect was most significant in anti-VEGF+Yiqi Huoxue Jiedu decoction. Conclusion: Yiqi Huoxue Jiedu decoction can restrict the multiplication of ovarian epithelial carcinoma ID-8 cells
and it could intervene the angiogenesis of HUVECs
which is probably associated with the intervention on Tregs.
Clinical Research on Guizhi Fulingwan in Treatment of Ovarian Cancer: A Review
Gypenoside L Regulates piR-hsa-2804461/FKBP8/Bcl-2 Axis to Promote Apoptosis and Inhibit Ovarian Cancer
Exploring Molecular Mechanism of Gypenoside L against Ovarian Cancer Based on Ferroptosis Pathway Mediated by Mature-tRNA-Asp-GTC/ATF3-LPCAT3
Molecular Mechanism of Treating Different Diseases with Same Treatment of Gypenoside L Affecting Oxidative Damage HUVEC and OVCAR-3 Through EGFR/STAT3/Glycolytic Pathway
Molecular Mechanism of Gypenoside L in Anti-Ovarian Cancer by Affecting GCK-Mediated Glycolytic Pathway
Related Author
GUAN Muxin
FENG Jiaxing
ZHU Mengyi
WANG Yu
WU Xiaoke
DONG Yuanguang
SUN Yinying
YUAN Mingdian
Related Institution
The First Affiliated Hospital of Heilongjiang University of Chinese Medicine
Heilongjiang University of Chinese Medicine
Liaoning Provincial Hospital of TCM
Liaoning University of Traditional Chinese Medicine(TCM)